Myriad Genetics, Inc. (MYGN) Dividend Yield, History & Forecast

Myriad Genetics, Inc. (MYGN) is a Medical - Diagnostics & Research company in the Healthcare sector listed on the NASDAQ. The most recent ex-dividend date was July 1, 2009. market capitalization is approximately $607M.

Loading quote...

Frequently Asked Questions about Myriad Genetics, Inc. (MYGN)

When does Myriad Genetics, Inc. pay its next dividend?
The most recent ex-dividend date was July 1, 2009.
Is Myriad Genetics, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Myriad Genetics, Inc. in?
Myriad Genetics, Inc. (MYGN) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry.